SARS-CoV-2 XBB.1.16 variant: India in focus?

J Med Virol. 2023 May;95(5):e28829. doi: 10.1002/jmv.28829.

Ryan Varghese^{1

2

3}, Sanidhya Pai^{2

3

4}, Dileep Kumar^{1

5

6}, Rohit Sharma⁷

¹ Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, India.
² Department of Clinical Pharmacology, Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
³ Homi Bhabha National Institute, Mumbai, Maharashtra, India.
⁴ Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka, India.
⁵ Department of Entomology, University of California, Davis, California, USA.
⁶ UC Davis Comprehensive Cancer Center, University of California, Davis, California, USA.
⁷ Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

No abstract available

Publication types